title: Rituximab in refractory MuSK antibody myasthenia gravis.
authors.forename: Mona
authors.initials: M
authors.lastname: Thakre
authors.forename: Jihad
authors.initials: J
authors.lastname: Inshasi
authors.forename: Mahmoud
authors.initials: M
authors.lastname: Marashi
mesh_terms: D000328:Adult; D000906:Antibodies / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D009157:Myasthenia Gravis / Q000097:blood / Q000276:immunology / Q000628:therapy; D020794:Receptor Protein-Tyrosine Kinases / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*; D000069283:Rituximab
chemical_list: D000906:Antibodies; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D011950:Receptors, Cholinergic; D000069283:Rituximab; C095714:MUSK protein, human; D020794:Receptor Protein-Tyrosine Kinases